Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...
We recently published a list of 10 Stocks Kick Off Trading Week With Losses. In this article, we are going to take a look at ...
TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...
We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...
We recently compiled a list of the Last Week’s Top 10 Stocks Post Double-Digit Gains. In this article, we are going to take a ...
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was down 4.4% during mid-day trading on Friday after an insider sold shares in the company. The stock traded as low as $71.50 and last traded at $73.34.
Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) have received an average rating of “Moderate Buy” from the twelve ...
Tempus announced its acquisition of Ambry Genetics at closing in November and the deal closed earlier this month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...
Tempus AI (TEM) and Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, announced a new collaboration. The two companies ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...